Dr. Christopher Corless, Dr. Carol Beadling, Dr. Yassmine Akkari and other members of the of the Knight Diagnostic Laboratories, contributed to two posters presented at AMP
As part of the NHGRI CSER Consortium, The Knight Diagnostic Laboratories collaborated on the classification and Sanger confirmation of variants detected through carrier screening of healthy women presenting for preconception genetic testing using Whole Genome Sequencing (WGS).
In a poster presented at AMP, Dr. Yassmine Akkari describes our findings in the first four patients and discuss potential issues that arise when screening a population of healthy individuals.
Dr. Christopher Corless, Dr. Carol Beadling and other members of the of the Knight Diagnostic Laboratories, contributed to two posters. One discussed Amplification-Based Next-Gen Sequencing Panel For the Detection of Actionable Gene Fusions in Cancer and the second discussed the Impact of Next-Generation DNA Sequencing in GI Malignancies.